Developing robust eligibility criteria is critical for a trial’s success. Not only is it important to define who gets to participate in the trial, but it’s equally important to define who doesn’t. A subset of patients are being robbed of access to innovative treatments because they’re often excluded from drug trials that could help them.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,